Medtronic Stock
Medtronic Plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Ireland
- CEO
- Geoffrey Straub Martha
- Employees
- 95,000
- Market cap
- $121.2 B
- IPO
- 02/05/1973
Medtronic Plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. Serving healthcare systems, clinicians, physicians, and patients worldwide, the company is headquartered in Galway, Ireland. The operations are…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Medtronic stock: price history
1D
-0.7%
1W
+7.1%
1M
+2.3%
6M
+9.9%
YTD
-1.4%
1Y
-0.3%
2Y
+5.3%
5Y
-25.8%
10Y
+14.6%
Next earnings date
Next earnings date
17/11/2026 (in 31 days)
Volatility around earnings
~31% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vrange-breakout-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Range breakout
BullishThe price has broken out of a longer sideways range (support and resistance) to the upside or downside. In technical analysis, this is read as a signal that a new trend is starting in the breakout direction.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Medtronic stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
3 more assignments (Enabler/Second row) Pro-only.
Medtronic plc is a leading global provider of medical technology that develops and distributes a broad range of medical therapies. The business model encompasses highly specialized segments such as cardiac and vascular technology, surgery, neuroscience, and diabetes management. The product portfolio ranges from complex hardware solutions like pacemakers and surgical robotic systems to accompanying consumables and software applications for patient monitoring. The company combines sales of one-time medical devices with recurring revenues through specialized consumables, for example in the diabetes care sector.
- Revenue model
- Mixed
- Recurring revenue
- None
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Brand / IP
- Capital intensity
- High
- Customer concentration
- Low
Ask the agents about Medtronic
Analyst assessment of Medtronic
PRICE TARGET LOW
US$83.00
CONSENSUS
US$97.73
MEDIAN
US$97.00
PRICE TARGET HIGH
US$115.00
1
STRONG BUY
30
BUY
20
HOLD
0
SELL
0
STRONG SELL
51
TOTAL · Buy
As of: 12/10/2026
Medtronic stock metrics
P/E
23.17
P/B
2.41
EV/EBITDA
14.51
RETURN ON EQUITY
2.9%
NET MARGIN
15.1%
DEBT/EQUITY
0.56
DIVIDEND YIELD
3.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
99.9%
FLOAT SHARES
1,278,054,564
AVG. DAILY VOLUME (30D)
25,519,208
Insider transactions (SEC)
Martha Geoffrey
Medtronic plc
Marinaro Michael
KIIL HARRY SKIP
Blomquist Denise L.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.7%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Medtronic stock
What does Medtronic do?
Medtronic Plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in Ireland.
The CEO is Geoffrey Straub Martha, the company employs around 95,000 people.
The IPO was on 02/05/1973; the stock trades on NYSE under the ticker MDT.
What do analysts say about Medtronic stock?
51 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$97.73, ranging from US$83.00 to US$115.00, with a median of US$97.00.
This is an external assessment, not a statement by Market Jury.
When does Medtronic report next?
The next earnings date is 17/11/2026.
Around past earnings, price swings were roughly 31% stronger than usual.
Does Medtronic pay a dividend?
Yes. The last dividend was US$0.72 per share, ex-date 25/09/2026, paid on 16/10/2026.
The dividend yield is 3.0% (as of 31/07/2026).
Which stocks are comparable to Medtronic?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, DexCom, GE HealthCare Technologies and Koninklijke Philips.
How can I get Medtronic stock analyzed?
Clicking "Analyze stock" lets five strategies assess Medtronic against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.